Home Search
gene therapy - search results
If you're not happy with the results, please do another search
Incontinence treatment through bioelectrical implant therapy
In a current incontinence treatment, researchers are exploring how to physically regulate bladder function by bioelectrical implant signals.
Degenerative eye disease and the opportunities of ophthalmic drug development
Eric Buckland of Translational Imaging Innovations looks at ophthalmic drug development and how better clinical endpoints can improve success rates.
Understanding Hydra Regeneration
Here, Charisios Tsiairis from Friedrich Miescher Institute for Biomedical Research explores Hydra Regeneration and the genetic programs that make it possible.
Increasing blood-brain barrier permeability with Acoustic Cluster Therapy (ACT®) to enhance drug delivery in...
Despite the rising incidence of Central Nervous System diseases worldwide, efficient treatment options for neurological disorders remain scarce. Treatment failures are principally associated with the inability of drugs to pass the highly selective Blood-Brain Barrier rather than a lack of efficacy.
What are the physical health benefits of cold water therapy?
Coldwater therapy means exposing the body to cold temperatures by immersing the body in cold water. This might be by cold water swimming or taking cold water showers or baths.
Stem cell-based therapy for corals
Could medical approaches of stem cell-based therapy, be a tool for corals’ resilience to heat stress? Benyamin Rosental, Principal Investigator, Assistant Professor at Ben Gurion University of the Negev in Israel answers the compelling question here.
Talk therapy to improve mental health in dementia patients
Could talk therapy help dementia patients improve their mental health? Research suggests that it is beneficial for anxiety and depression.
Improving the quality of life for people with brittle bone disease: Osteogenesis Imperfecta
Pascale V Guillot, at the University College London, looks toward improving the quality of life for those with Osteogenesis imperfecta, a chronic health condition called brittle bone disease.
Preparing Europe for a new generation of innovative therapies
Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA and APAC at PTC Therapeutics explores how preparing Europe for a new generation of innovative therapies has the potential to transform the lives of patients.
Data capture for researching degenerative eye disease
Translational Imaging Innovations makes data accessible to research degenerative eye disease.
Cerebral creatine deficiency syndrome through genetic treatments
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, addresses cerebral creatine deficiency syndrome through genetic treatments.
Natural vibration therapy to combat osteoporosis
MyBones explores the potential Low-intensity Vibration therapy has as a natural alternative to prevent and combat osteoporosis.
Imaging & radiation oncology core: Improving radiotherapy quality & care
The Imaging and Radiation Oncology Core is part of the U.S. National Cancer Institute’s clinical trial program and provides quality assurance for trials with radiation oncology and/or imaging.
Improving the quality of life for people with brittle bone disease: Osteogenesis Imperfecta
Pascale V Guillot, at the University College London, looks toward improving the quality of life for those with Osteogenesis imperfecta, a chronic health condition called brittle bone disease.
Gender Affirming Hormone Therapy reduces suicidal ideation
People who undergo Gender Affirming Hormone Therapy have high grades of satisfaction with the physical and psychological effects – and have fewer suicidal thoughts.
Individualised Multimodal Immunotherapy beyond personalised medicine for brain cancer
Stefaan Van Gool, MD, PhD brings to light the important role of Individualised Multimodal Immunotherapy in improving the survival of brain cancer.
The future of living with Osteogenesis Imperfecta
CEO of Brittle Bone Society Patricia Osborne, revisits aspects of the condition and shares what is known around current medical research and treatments, speaking to experts attached to the Charity.
TheraVision: An oncolytic virus platform technology for a personalised virus-immunotherapy
Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.
Exosome therapy for brittle bone disease
Pascale V Guillot, Associate Professor at University College London, investigates the possibility of exosome therapy for those living with brittle bone disease.
Prospects for minimally invasive and optimally effective cancer immunotherapy
Here, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, Peter Betscher, explains how he is dedicated towards realising Robert North’s vision.